Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Neoplasms 5Breast Neoplasms 3Urinary Bladder Neoplasms 2Prostatic Neoplasms 2Leukemia, Myeloid, Acute 2Colorectal Neoplasms 2Cardiovascular Diseases 2Uterine Cervical Dysplasia 1Triple Negative Breast Neoplasms 1Pulmonary Disease, Chronic Obstructive 1Prostatic Intraepithelial Neoplasia 1Osteoporosis 1Neuralgia 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Motor Activity 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Hematologic Neoplasms 1Fatigue 1Eye Diseases 1Cognitive Dysfunction 1Breast Neoplasms, Male 1Bone Diseases, Metabolic 1Blast Crisis 1

Interventions

Gemcitabine 87Cisplatin 66Cystectomy 38pembrolizumab 34Docetaxel 25Nivolumab 24durvalumab 21Paclitaxel 19Magnetic Resonance Spectroscopy 18Radiotherapy 17Mitomycin 17Carboplatin 16atezolizumab 15Doxorubicin 14Cystoscopy 14BCG Vaccine 13Surveys and Questionnaires 12Standard of Care 12avelumab 11Sunitinib 10tremelimumab 9Transurethral Resection of Bladder 9Ipilimumab 9Filgrastim 9Blood Specimen Collection 9Specimen Handling 8Neoadjuvant Therapy 8Methotrexate 8Methods 8Early Intervention, Educational 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Urinary Bladder Neoplasms × Geritol × Clear all
NCT02050451 2017-03-29

Perioperative Oral Nutrition Intervention for Patients Undergoing Radical Cystectomy

Vanderbilt University Medical Center

Phase NA Completed
60 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT00003623 2016-07-13

High-Dose Multivitamins Compared to a Placebo in Preventing the Recurrence of Cancer in Patients With Early Stage Bladder Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
21 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡